Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110alpha/beta/delta/gamma, mTORC1/2, respectively. Omipalisib has anti-cancer activity[1][2][3].
Molecular Weight:
505.50
Purity:
99.94
CAS Number:
[1086062-66-9]
Formula:
C25H17F2N5O3S
Target:
Autophagy,mTOR,PI3K
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
